Lidocaine Market Report 2018-2026 by Key Players: Pfizer, AstraZeneca, Glenmark, Taro Pharma
The global Lidocaine Market is expected to reach USD 5.6 Billion by 2026, according to a new report by Reports and Data. This can be mainly associated with the incidences of various minimally invasive surgical procedures, periodontal diseases and carries, inclination towards preventive healthcare, incidences of cosmetic procedures, incidences of painful disorders and growing applications in anti-itching and pain relief drug, associated with minor cuts, insect's bites, skin scrapes, burns and eczema.
View full press release